Designer drug

As per available reports about 05 relevant journals, 06 Conferences, 05 Workshops are presently dedicated exclusively to Auditing and about 24 articles are being published on  Clinical Global Impression.

International standards are standards developed by international standards organizations. International standards are available for consideration and use worldwide. One prominent organization is the OMICS International Organization for Standardization. International standards may be used either by direct application or by a process of modifying an international standard to suit local conditions.

OMICS International Organizes 1000+ Global Events every Year across USA, Europe & Asia with support from 1000 more scientific societies  and Publishes 700+  Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug while at the same time, avoid being classified as illegal and/or avoid detection in standard drug tests. Designer drugs include psychoactive substances that have been designated by the European Union as new psychoactive substances (NPS) as well as analogs of performance-enhancing drugs such as designer steroids. Some of these were originally synthesized by academic or industrial researchers in an effort to discover more potent derivatives with less side effects and were later co-opted for illicit use. Other designer drugs were prepared for the first time in clandestine laboratories. Because the efficacy and safety of these substances has not been thoroughly evaluated in animal and human trials, the use of these drugs may result in unexpected side effects.

The development of designer drugs may be considered a subfield of drug design. The exploration of modifications to known active drugs — such as their structural analogues, stereoisomers, and derivatives — yields drugs that may differ significantly in effects from their “parent” drug (e.g., showing increased potency, or decreased side effects.

List of Best International Conferences:

• International Conference and Expo on Biopharmaceutics, September 21-22,  Baltimore 2015

• Asia Pacific Drug Formulation & Bioavailability Congress June 06-08, 2016 Beijing, China

• 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey

• 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA

• 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, September 26-28, 2016 Miami, USA

Associations:

American Association of Poison Control Centers

Ministry Health Center

PCAB Accredited Pharmacy

Central Drug Research Institute

This page will be updated regularly.

This page was last updated on April 25, 2024